Am J Physiol Cell Physiol AJP: Heart and Circulatory Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Cell Physiol 295: C81-C91, 2008. First published April 30, 2008; doi:10.1152/ajpcell.00028.2008
0363-6143/08 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/1/C81    most recent
00028.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, B.
Right arrow Articles by Zhang, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, B.
Right arrow Articles by Zhang, H.

MEMBRANE TRANSPORTERS, ION CHANNELS, AND PUMPS

Phosphatidylinositol 4,5-bisphosphate hydrolysis mediates histamine-induced KCNQ/M current inhibition

Boyi Liu, Huiling Liang, Li Liu, and Hailin Zhang

Department of Pharmacology, Hebei Medical University, Shijiazhuang, Hebei Province, China

Submitted 22 January 2008 ; accepted in final form 27 April 2008


   ABSTRACT
TOP
 ABSTRACT
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
The M-type potassium channel, of which its molecular basis is constituted by KCNQ2-5 homo- or heteromultimers, plays a key role in regulating neuronal excitability and is modulated by many G protein-coupled receptors. In this study, we demonstrate that histamine inhibits KCNQ2/Q3 currents in human embryonic kidney (HEK)293 cells via phosphatidylinositol 4,5-bisphosphate (PIP2) hydrolysis mediated by stimulation of H1 receptor and phospholipase C (PLC). Histamine inhibited KCNQ2/Q3 currents in HEK293 cells coexpressing H1 receptor, and this effect was totally abolished by H1 receptor antagonist mepyramine but not altered by H2 receptor antagonist cimetidine. The inhibition of KCNQ currents was significantly attenuated by a PLC inhibitor U-73122 but not affected by depletion of internal Ca2+ stores or intracellular Ca2+ concentration ([Ca2+]i) buffering via pipette dialyzing BAPTA. Moreover, histamine also concentration dependently inhibited M current in rat superior cervical ganglion (SCG) neurons by a similar mechanism. The inhibitory effect of histamine on KCNQ2/Q3 currents was entirely reversible but became irreversible when the resynthesis of PIP2 was impaired with phosphatidylinsitol-4-kinase inhibitors. Histamine was capable of producing a reversible translocation of the PIP2 fluorescence probe PLC{delta}1-PH-GFP from membrane to cytosol in HEK293 cells by activation of H1 receptor and PLC. We concluded that the inhibition of KCNQ/M currents by histamine in HEK293 cells and SCG neurons is due to the consumption of membrane PIP2 by PLC.

superior cervical ganglion; phosphatidylinositol 4,5-bisphosphate; calcium ion

M CURRENT IS A VOLTAGE-GATED, slowly activating, slowly deactivating, and noninactivating K+ current, which presents in many types of neurons and plays a key role in modulation of cell excitability (8). Blocking of M channel results in membrane depolarization, which makes the cell more likely to fire action potentials (2). At present, the molecular correlates of M current have been identified as the KCNQ2-5 homo- or heteromultimers (9). It has now become widely known that M current is inhibited not only by muscarinic M1 receptor activation but also by the activation of many other G protein-coupled receptors (GPCR), agonists for such receptors includind bradykinin, angiotensin II, UTP, etc. (12, 26, 34). Until now, GPCRs that mediate M current inhibition all share a common feature, which is, they are coupled to the Gq/11 signaling pathway, which leads to activation of phospholipase C (PLC), and then the hydrolysis of membrane phosphatidylinositol 4,5-bisphosphate (PIP2). In general, many effectors involved in the Gq/11 pathway have been reported to participate in the receptor-mediated M current modulation, such as PIP2, Ca2+, calmodulin (CaM), phosphokinase C (PKC), and AKAP150, etc. (16, 24, 32, 45).

Muscarinic M1 and bradykinin B2 receptors are among the receptors that have received the most extensive studies. In rat superior cervical ganglion (SCG) neurons, activation of these two receptors can both produce prominent M current inhibition. Although both receptors are coupled to Gq/11 protein, they take distinct downstream signaling pathways to fulfill their role in M current modulation in the SCG. Bradykinin, a B2 receptor agonist, evokes intracellular Ca2+ concentration ([Ca2+]i) signals through PLC signaling pathway. Its modulation of M current is largely dependent on Ca2+-CaM pathway (16), whereas oxo-M, an M1 receptor agonist that hardly elicits [Ca2+]i signals, suppresses M current by PIP2 depletion. Such a distinction in these two Gq/11-mediated M current modulations may originate from the specificity of the "signaling microdomains," formed by clustering of some Gq/11-coupled receptors together with inositol 1,4,5-trisphosphate (IP3) receptors, which allows some certain agonists like bradykinin, but not others, like oxo-M, to raise [Ca2+]i (10, 11).

Histamine is an endogenous and widely distributed amine transmitter that mediates numerous physiological processes. Among the four different types of histamine receptors that have been identified (H1, H2, H3, and H4), H1 receptor is known to proceed via Gq/11 to activate PLC and hydrolyze membrane PIP2 (4). Evidence has been accumulating which suggests that histamine produces depolarization and promotes neuron excitability by inhibiting K+ currents via H1 receptor stimulation (27, 41, 46). As far as KCNQ/M channels are concerned, histamine inhibits heteromeric KCNQ2/Q3 channels transfected in human embryonic kidney (HEK)293 and Hela cells via recombinant H1 receptor (20, 21). In addition, it is also demonstrated that histamine inhibits M current in bovine adrenal chromaffin cells via H1 receptor stimulation, leading to enhanced membrane excitability (40). It is suggested that the activation of a pertussis toxin-insensitive G protein is involved in histamine H1 receptor modulation of KCNQ2/Q3 currents (20), yet the downstream signals are still not clearly revealed. It is still not known whether histamine modulates M current in native neurons.

In the present study, we use pharmacological and electrophysiological approaches to show that histamine-induced inhibition of KCNQ2/Q3 currents in HEK293 cells is due to membrane PIP2 hydrolysis via PLC stimulation. We further demonstrate that histamine also inhibits M current in rat SCG neurons via stimulation of H1 receptor and PLC. By comparing the effects of histamine on SCG neurons with those of the well-characterized M1 and B2 receptor agonist, oxo-M, and bradykinin, we suggest that histamine inhibits M current in a similar mechanism with oxo-M.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
cDNA constructs. Plasmids encoding human KCNQ2 and rat KCNQ3 (GenBank accession numbers: AF110020 and AF091247) and PLC{delta}1-PH-GFP were kindly provided by Diomedes E. Logothetis (Mount Sinai School of Medicine, New York, NY). Human histamine H1 receptor was obtained from Missouri S&T cDNA Resource Center (Rolla, MO).

HEK293 cell culture and transfection. HEK293 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (Maveric) and antibiotics in a humidified incubator at 37°C (5% CO2). Cells were seeded on poly-D-lysine-coated glass coverslips in a 24-multiwell plate and transfected when 60–70% confluence was reached. For transfection of six wells of cells, a mixture of 3 µg KCNQ, pEGFP-N1 cDNAs, H1 receptor, and 3 µl Lipofectamine 2000 reagent (Invitrogen) was prepared in 1.2 ml of DMEM and incubated for 20 min according to manufacturer's instruction. The mixture was then applied to the cell culture wells and incubated for 4–6 h. Recordings were made 24 h after cell transfection and cells were used within 48 h.

Rat SCG neuron culture. SCGs were isolated from 10- to 17-day-old Sprague-Dawley rats, cut into pieces, and then transferred into collagenase solution (1 mg/ml) and incubated for 30 min at 37°C. The ganglia were then placed into trypsin solution (2.5 mg/ml) for 30 min at 37°C. The digested fragments were then rinsed three times with 2 ml DMEM plus 10% fetal bovine serum, centrifuged, and dissociated by trituration. The ganglia were plated onto glass coverslips precoated with poly-D-lysine and incubated at 37°C. After the neurons had attached to the coverslips, cell culture medium was changed to Neurobasal plus B27 supplement (Invitrogen). Neurons were cultured for 1 day and used within 24 h.

Electrophysiology. For current measurements in SCG neurons and HEK293 cells, recordings were performed using whole cell configuration of patch-clamp technique. Signals were amplified using an Axopatch 700B patch-clamp amplifier (Axon Instruments) and filtered at 2 kHz. Patch electrodes were pulled with a Flaming/Brown micropipette puller (Sutter Instruments) and fire-polished to a final resistance of 4–6 M{Omega} when filled with internal solution. Data acquisition was achieved using pClamp 9.1 software. Current recording was repeated every 4 s. The normal internal solution (low BAPTA) for HEK293 cell and rat SCG neuron recording was as follows (in mM): 175 KCl, 5 MgCl2, 5 HEPES, 0.1 BAPTA, 3 K2ATP, and 0.1 NaGTP, pH 7.4 adjusted with KOH. The internal solution for calcium clamping (high BAPTA) was as follows (in mM): 115 KCl, 5 MgCl2, 5 HEPES, 20 BAPTA, 3 K2ATP, 0.1 NaGTP, and 10 CaCl2, pH 7.4 adjusted with KOH. The external solution for HEK293 cells contained (in mM) 160 NaCl, 2.5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, and 8 glucose, pH 7.4 adjusted with NaOH. For recordings from SCG neurons, the CaCl2 concentration was 5 mM. The KCNQ/M current amplitude was measured from the deactivation current records as the difference between the average of a 10-ms segment, taken 20–30 ms into the hyperpolarizing step, and the average during the last 50 ms of that step (7).

The perfusion system was a homemade 100-µl perfusion chamber through which solution flowed continuously at 1–2 ml/min. Drugs were applied to cells by gravity via a BPS-8 valve control system (Scientific Instruments). All recordings were carried out at room temperature.

Intracellular Ca2+ measurements. HEK293 cells or rat SCG neurons were loaded with dual excitation calcium indicator fura-2 acetoxymethyl ester (fura-2 AM, 2.5 µM) for 45 min at 37°C in the dark. After loading was completed, the cells were then washed with normal extracellular solution twice and were allowed to rest for 30 min at 37°C protected from light. Fluorescence microscopy was performed with an inverted Nikon Eclipse TE2000-S microscope (Tokyo, Japan) with x40/0.6 numerical aperture objective. The intracellular fura-2 was excited alternately with light of 340 and 380 nm by Polychrome V monochromator (T.I.L.L. Photonics, Martinsreid, Germany), and the fluorescence emission at the wavelength of 510 nm was collected by Hamamatsu ORCA-ER 48-bit cooled CCD camera (Hamamatsu, Japan). The images were analyzed off-line with SimplePCI 6.0 software supplied by Compix Imaging (Sewickley).

Confocal imaging. HEK293 cells were grown on glass coverslips and transfected with PLC{delta}1-PH-GFP and histamine H1 receptor. One day after transfection, the coverslips were placed into a flow-through chamber. For confocal imaging, an inverted Leica DM-IRBE microscope (Heidelberg, Germany) with a x20/0.7 numerical aperture objective and TCS-SP2 scanner was used. Excitation of PLC{delta}1-PH-GFP was accomplished with a 488-nm argon laser beam, and emission was collected from 500 to 560 nm. Laser intensity and pinhole settings were kept constant during studies. Pinhole size was set to scan sections with a thickness of 0.28 µm. Determination of the fluorescence was accomplished by assigning regions of interest in the cytosol and membrane. Leica TCS-SP2 confocal software was used to analyze the data offline.

Western blot. Isolated rat SCGs were cut into small pieces and sonicated in 200 µl of radioimmunoprecipitation assay lysis buffer containing protease inhibitors (0.01 µg/µl pepstatin A, 0.025 µg/µl leupeptin, 0.01 µg/µl aprotinin, 0.03 µg/µl PMSF) for 20 min at 0°C. SCG homogenates were centrifuged at 18,000 rpm at 4°C for 20 min, and the pellets were discarded. The concentration of protein in the supernatant was assessed by BCA assay (Pierce, Rockford, IL), a loading buffer (10% SDS, 0.5 M Tris·HCl, 50% glycerol, 0.24% bromophenyl blue, and 20% ME) was added, and it was incubated at 70°C for 10 min. Proteins were fractionated on SDS-PAGE, transferred to polyvinyl difluoride membranes, and blotted with a rabbit anti-histamine receptor antibody (1:200; Santa Cruz Biotechnology, Santa Cruz, CA). Bands were visualized with chemiluminescence from goat anti-rabbit horseradish peroxidase coupled secondary antibodies (Zhongshan, Beijing, China).

Chemicals. Histamine, mepyramine, cimetidine, oxo-M, bradykinin, phenylarsine oxide, wortmannin, U-73122, and fura-2 AM were purchased from Sigma (St. Louis, MO). The solutions containing antihistamines, U-73122, and wortmannin were all freshly prepared from stock solutions before each experiment and kept away from light exposure.

Data analysis and statistics. Currents were analyzed and fitted using Clampfit 9.1 (Axon Instrument) and Origin 7.0 (Originlab) software. The concentration-response curve was fitted by logistic equation: y = A2 + (A1 – A2)/[1 + (x/x0)p], where y is the response; A1 and A2 are the maximum and minimum response, respectively, x is the drug concentration, and p is the Hill coefficient.

Results were expressed as means ± SE. Statistical analysis of differences between groups was carried out using Student's t-test, paired t-test or one-way ANOVA. The differences were considered significant if P < 0.05.


   RESULTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 GRANTS
 REFERENCES
 
Histamine suppresses KCNQ/M current in HEK293 cells and rat SCG neurons via activation of H1 receptor. We first evaluated the effects of histamine H1 receptor stimulation on KCNQ2/Q3 channel currents heterologusly expressed in HEK293 cells. Upon transfection with KCNQ2, KCNQ3, and H1 receptor cDNAs, HEK293 cells yielded a slowly activating, slowly deactivating, and noninactivating outward current with neuronal M current-like properties (Fig. 1A, inset). The KCNQ currents were measured from the deactivation tail current at –60 mV. Bath application of 10 µM histamine caused a significant inhibition of KCNQ2/Q3 currents (Fig. 1A). To confirm the inhibitory effect of histamine on KCNQ2/Q3 currents was due to H1 receptor activation but not some unspecific actions, mepyramine and cimetidine, the specific H1 and H2 receptor antagonists, respectively, were applied before histamine application. H1 receptors mediated the inhibitory effect of histamine on KCNQ2/Q3 currents since mepyramine (1 µM) totally abolished the inhibitory effect (Fig. 1B), whereas cimetidine (10 µM) did not (Fig. 1C). The KCNQ2/Q3 currents usually fully recovered after the removal of histamine under whole cell patch configurations (Fig. 1A), and no obvious desensitization of H1 receptor effect was observed even after successive applications of histamine (data not shown). Histamine application suppressed the KCNQ2/Q3 currents by 77.9 ± 3.5% (n = 28) and 76.8 ± 6.1% (n = 6) in control cells and in cells treated with cimetidine, respectively (Fig. 1G). But the suppression was only 1.8 ± 0.4% (P < 0.01 vs. control, n = 7, Fig. 1G) when cells were treated with mepyramine. Thus these data indicate that H1 receptor stimulation can induce KCNQ2/Q3 current inhibition in HEK293 cells, which is consistent with a previous report (21). It is also noteworthy that in the present study (data not shown) and in our previous report (29), we found that mepyramine would on its own cause a remarkable inhibition of KCNQ/M currents at higher concentrations (>10 µM), which in turn would mask its effect on antagonizing H1 receptor.


Figure 1
View larger version (24K):
[in this window]
[in a new window]

  		Fig. 1. Histamine inhibits KCNQ2/Q3 and M currents via histamine H1 receptor. Human embryonic kidney (HEK) 293 cells were transiently transfected with KCNQ2/Q3 subunits and H1 receptors. The current amplitudes were quantified as the deactivating tail current at –60 mV. Time course for the effect of 10 µM histamine on KCNQ2/Q3 currents in control condition (A) and in the presence of 1 µM mepyramine (B) and 10 µM cimetidine (C) is shown. Time course for the effect of 10 µM histamine on M currents of rat superior cervical ganglion (SCG) neurons in control condition (D) and in the presence of 1 µM mepyramine (E) and 10 µM cimetidine (F) is shown. Insets denote the pulse protocol and representative current traces recorded during experiments. Dashed line in the current trace indicates the zero current level. G: summary of the percent inhibitions of KCNQ2/Q3 and M currents by histamine for the three groups of cells. **P < 0.01. Error bars indicate SE.

 
We then investigated whether histamine also inhibited M current in native rat SCG neurons. M currents were recorded using whole cell patch-clamp configuration and measured from the deactivation tail current at –60 mV (for details, see MATERIALS AND METHODS). For this part of the experiments, we used a slightly different voltage-clamp protocol from that used for HEK293 cells: membrane potential was held continuously at –20 mV before stepping to –60 mV. This would inactivate many voltage-dependent channels (Na+, Ca2+) present in SCG neurons but was negligible in HEK293 cells. Application of histamine (10 µM) induced an obvious inhibition of M current. The mean inhibition of M current by 10 µM histamine was 33.1 ± 2.9% (n = 11, Fig. 1, D and G). Histamine receptors have been demonstrated in SCG by electrophysiological studies (6, 36). To determine which receptor subtype was responsible for histamine-induced M current inhibition, histamine was applied to neurons in either the presence of mepyramine (1 µM) or cimetidine (10 µM). In the presence of mepyramine, histamine-induced M current inhibition was almost completely abolished (1.1 ± 0.5%, n = 7, P < 0.01 vs. control, Fig. 1, E and G), whereas in the presence of cimetidine, the inhibitory response was 30.2 ± 3.1% (n = 5), which was not significantly different from that of the control (P > 0.05, Fig. 1, F and G). Therefore, the above results suggest that histamine inhibits M current in rat SCG neurons via H1 receptor stimulation. We noticed that the baseline of KCNQ/M current (recorded at –60 mV) in SCC neurons also decreased in the presence of histamine. This could be due to inhibition of a nondeactivating component of KCNQ/M current or/and induction of an inward potassium current (5).

The concentration-dependent effects of histamine on rat SCG neurons were then tested, and the concentration response relationship was established. Histamine began to inhibit M current at a concentration of 1 µM and reached the maximal inhibition (~40%) at a concentration of 100 µM. The concentration of histamine needed to produce half-maximal inhibitory effect (EC50) of M currents was estimated to be 3.3 ± 1.1 µM (Fig. 2). To provide additional evidence that the observed inhibitory effects of histamine were mediated through activation of H1 receptor, a Western blot study was performed to confirm the presence of H1 receptor in rat SCG neurons. A band with the expected size of H1 receptor was recognized by anti-H1 receptor antibody (Fig. 2, inset) from SCG preparations.


Figure 2
View larger version (12K):
[in this window]
[in a new window]

  		Fig. 2. Concentration dependence of M current inhibition by histamine in SCG neurons. Line represents the fit of experimental data to the logistic equation, as described in MATERIALS AND METHODS. Current responses were measured with the tail current at –60 mV, proceeded by an activating step at –20 mV. Error bars indicate SE. Inset shows Western blot analysis revealing a single band of 56 kDa for the expression of H1 receptor in SCG neurons.

 
Histamine suppresses KCNQ/M current via activation of PLC. It is well established that H1 receptor couples to Gq/11, which commonly activates PLC. Our next step was to verify the involvement of PLC activity in histamine action on KCNQ/M channels. First, we tested the role of PLC in H1 receptor-mediated KCNQ2/Q3 current suppression in HEK293 cells. To address this issue, we used U-73122, which is a PLC inhibitor and is widely used as a quick test for the involvement of PLC in the signaling pathway (23). HEK293 cells, which were transfected with KCNQ2, KCNQ3, and H1 receptors, were challenged with histamine (10 µM) either in the presence of normal extracellular solution or 5 µM U-73122. Such a typical experiment is illustrated in Fig. 3, A and B. Histamine produced 74.5 ± 0.6% (n = 5) inhibition of KCNQ2/Q3 currents, and this was significantly reduced to 7.1 ± 0.6% (n = 5, P < 0.01, Fig. 3E, Student's paired t-test) when cells were treated with 5 µM U-73122 for 3 min. Interestingly, U-73122 on its own produced a transient augmentation of KCNQ2/Q3 currents, consistent with some previous reports (13, 23).


Figure 3
View larger version (20K):
[in this window]
[in a new window]

  		Fig. 3. Phospholipase C (PLC) is involved in histamine-induced suppression of KCNQ2/Q3 and M currents. HEK293 cells were transiently transfected with KCNQ2/Q3 subunits and H1 receptors. Time course for the effect of 10 µM histamine on KCNQ2/Q3 currents in control condition (A) or in cells treated with 5 µM U-73122 before application of histamine (B) is shown. Time course for the effect of histamine (10 µM) and oxo-M (10 µM) on M currents in control condition (C) or in neurons preincubated with 5 µM U-73122 for 10 min (D) is shown. Insets denote the corresponding current traces recorded. E: summary of the percent inhibitions of KCNQ2/Q3 and M currents by histamine and oxo-M in control conditions or in cells treated with U-73122. **P < 0.01. Error bars indicate SE.

 
Next, the role of PLC in native SCG neurons was tested. For this study, the effect of histamine was compared with that of muscarinic M1 receptor activation, a well-established system for modulation of M currents by PLC activity (23). In nontreated neurons, 10 µM histamine and 10 µM oxo-M, a specific M1 receptor agonist, could both suppress M currents by 36.6 ± 4.3% (n = 5) and 94.2 ± 3.0% (n = 5), respectively (Fig. 3, C and E). As expected, the inhibitory effect of oxo-M was significantly reduced to 10.7 ± 2.0% (Fig. 3, D and E; n = 5, P < 0.01 vs. inhibition in the absence of U-73122) when treated with U-73122 (5 µM), in accordance with some previous reports (23, 25). Furthermore, the inhibitory effect of histamine was also markedly reduced to 4.2 ± 0.8%, significantly different from the inhibition in the absence of U-73122 (Fig. 3, D and E; n = 5, P < 0.01). Taken together, the above data suggest that PLC activity is involved in histamine-induced KCNQ/M current inhibition.

Histamine-induced inhibition of KCNQ2/Q3 currents is the result of membrane PIP2 hydrolysis. PIP2 depletion, as a result of its hydrolysis triggered by PLC stimulation, was proposed to underlie KCNQ/M current inhibition by stimulation of certain Gq/11 protein-coupled receptors (17). Since PLC activity is involved in the histamine-induced inhibitory effect on KCNQ/M current, we thus hypothesize that histamine-induced KCNQ/M current inhibition may be due to membrane PIP2 hydrolysis. To address this issue, we start with confocal experiments to monitor the effect of histamine H1 receptor activation on the hydrolysis of membrane PIP2 in HEK293 cells. For this study, PLC{delta}1-PH-GFP, H1 receptor, and KCNQ2/Q3 channels were coexpressed in HEK293 cells. PLC{delta}1-PH-GFP is a green fluorescence probe known to bind PIP2, and its translocation between the membrane and the cytosol has been successfully used as a reporter of PIP2 breakdown and its resynthesis (37). Figure 4A (a–c) shows a typical HEK293 cell expressed with PLC{delta}1-PH-GFP probe before, during, and after application of 10 µM histamine. Figure 4B examines the time course of histamine action on the fluorescence intensity of the membrane and cytoplasmic region of interest. The fluorescence intensity was normalized based on its initial level before application of histamine. Histamine induced a remarkable and reversible translocation of green fluorescence signal, suggesting translocation of the probe from the membrane to the cytosol and vice versa upon its application and washout (Fig. 4B). The translocation of the fluorescence probe was completely blocked when cells were treated with mepyramine (Fig. 4C) or U-73122 (Fig. 4D). These data are summarized in Fig. 4E. In these experiments, the rise of fluorescence signals in the cytosol evoked by application of histamine is 80.4 ± 6.0% (n = 13) but decreased to 1.5 ± 0.5% (n = 10, P < 0.01) and 2.5 ± 0.7% (n = 12, P < 0.01) in cells treated with mepyramine and U-73122, respectively. Thus our results indicate that histamine induces membrane PIP2 hydrolysis via stimulation of H1 receptor and PLC.


Figure 4
View larger version (20K):
[in this window]
[in a new window]

  		Fig. 4. Histamine translocates PLC{delta}1-PH-GFP via stimulation of H1 receptor and PLC. A: PLC{delta}1-PH-GFP was transiently expressed in HEK293 cells, and images were monitored with a confocal microscope. Cells in control condition (a), after treatment with 10 µM histamine (b), and washout (c) were illustrated in negative contrast. The cytoplasmic region of interest we examined is a cytoplasmic area adjacent to cell membrane and is illustrated in a black circle. Scale bar, 5 µM. Time course for the effect of histamine on PLC{delta}1-PH-GFP translocation in control condition (B) and in cells treated with mepyramine (C) or U-73122 (D) is shown. The translocation is measured as the ratio of the mean fluorescence intensity in the region of interest (F) to its initial value at the beginning of each experiment (F0). E: summary data of PLC{delta}1-PH-GFP translocation by histamine for the three groups of cells. **P < 0.01. Error bars indicate SE.

 
One strong piece of evidence suggesting PIP2 as the molecular determinant responsible for some GPCRs (such as M1 receptor)-mediated inhibition of KCNQ/M current came from experiments showing that a block of PIP2 resynthesis after its hydrolysis will lead to a block in the recovery of the inhibited KCNQ/M currents (38, 45). If PIP2 depletion is involved in histamine-induced KCNQ/M current inhibition, then its resynthesis would be required for the recovery of the current. To test this hypothesis, wortmannin, a fungal metabolite that could block phosphatidylinsitol-4-kinase (PI4 kinase) at micromolar concentrations and lead to the block of PIP2 resynthesis (38), was used in this study. HEK293 cells were cotransfected with KCNQ2/Q3 channels and H1 receptor. Figure 5A shows the different recovery rates of KCNQ2/Q3 currents in the absence and presence of 30 µM wortmannin. As before, application of histamine (10 µM) induced a strong inhibition of KCNQ2/Q3 current, which could recover almost back to its initial level after histamine removal in <2 min. However, the recovery phase of the histamine response was greatly slowed when the cell was treated with 30 µM wortmannin (Fig. 5A). In control conditions, the KCNQ2/Q3 currents recovered to 88.4 ± 6.2% (n = 7) of its initial level after 2 min, but in cells treated with wortmannin, the recovery was only 10.5 ± 3.4% (n = 8), which was significantly attenuated (P < 0.01). Notably, treating cells with 30 µM wortmannin for 3 min would on its own cause a gradual reduction (~50%) of the current, a phenomenon that may suggest a critical role for the tonic PI4 kinase activity in maintaining KCNQ2/Q3 channel activity.


Figure 5
View larger version (15K):
[in this window]
[in a new window]

  		Fig. 5. Current recovery from histamine-induced inhibition requires PIP2 resynthesis. A and B: HEK293 cells were transiently transfected with KCNQ2/Q3 subunits and H1 receptors. Histamine (10 µM), wortmannin (30 µM), and phenylarsine oxide (PAO, 30 µM) were applied by bath perfusion during the periods indicated by the bars. Insets denote the corresponding current traces recorded. C: summary of the percent recovery of currents after washout of histamine in control cells or cells treated with wortmannin (WMN) or PAO. **P < 0.01. Error bars indicate SE.

 
We next proceeded to use phenylarsine oxide (PAO) to block the resynthesis of PIP2. PAO, an arsenic-based compound that inhibits PI4 kinase at a concentration of 10 to 30 µM, has been used successfully to prevent the recovery of KCNQ2/Q3 current from M1 receptor-induced inhibition (38). HEK293 cells were pretreated with 30 µM PAO for 4 min before histamine (10 µM) application. Unexpectedly, application of PAO by itself produced a transient but pronounced argumentation of the current, which in turn returned to normal in the continued presence of PAO. As shown in Fig. 5B, 30 µM PAO almost completely blocked the current recovery after histamine application. In nontreated cells, KCNQ2/Q3 current recovered to 95.4 ± 4.6% (n = 5); however, in PAO-treated cells, the recovery was dramatically reduced to only 6.3 ± 0.9% (n = 5, P < 0.01). These data are summarized in Fig. 5C. In addition, wortmannin and PAO also strongly slowed the rate of membrane PIP2 recovery indicated by PLC{delta}1-PH-GFP translocation after histamine application (data not shown). All these results support the notion that delaying KCNQ2/Q3 channel recovery following histamine-induced inhibition by wortmannin or PAO is due to the attenuation of membrane PIP2 resynthesis. Thus the above results provide evidence that activation of histamine H1 receptor inhibits KCNQ2/Q3 currents in a mechanism that may involve PIP2 depletion.

Histamine inhibits KCNQ2/Q3 currents in HEK293 cells deprived of [Ca2+]i rises. In mammalian cell lines, the inhibition of KCNQ2/Q3 currents produced by activation of heterologously expressed Gq/11-coupled M1 or AT1 receptors was accompanied by robust [Ca2+]i rises (33, 43). To check if stimulation of H1 receptor expressed in HEK293 cells would also result in a similar effect, HEK293 cells were heterologously expressed with H1 receptor and loaded with a cell-permeant calcium indicator fura-2 AM for calcium imaging studies. [Ca2+]i was monitored by the fluorescence ratio at 340 and 380 nm (F340/380). As shown in Fig. 6A, the application of 10 µM histamine evoked a transient rise of [Ca2+]i, which then gradually declined to the baseline level within 100 s. This response involves PLC-mediated intracellular Ca2+ mobilization since the [Ca2+]i signal was only partially reduced in Ca2+-free bath solution but almost completely abolished by 5 µM U-73122 (Fig. 6A).


Figure 6
View larger version (24K):
[in this window]
[in a new window]

  		Fig. 6. Suppression of intracellular Ca2+ concentration ([Ca2+]i) rises does not abolish histamine-induced inhibition of KCNQ2/Q3 currents in HEK293 cells. HEK293 cells were transiently transfected with KCNQ2/Q3 subunits and H1 receptors. A: superimposed time courses for changes in F340/F380 ratio of HEK293 cells upon application of histamine (10 µM) in extracellular solutions containing 2 mM Ca2+, Ca2+-free, or 5 µM U-73122. HEK293 cells were bath loaded with fura-2 AM before calcium photometry study. Whole cell recordings of HEK293 cells dialyzed with pipettes containing either the low BAPTA (B) or high BAPTA intracellular solution (C) are shown. Each cell was allowed for dialysis at least for 12 min before histamine application. Bottom panels indicate histamine-induced [Ca2+]i changes in HEK293 cells dialyzed with either low or high BAPTA solutions. D: effect of depleting internal Ca2+ stores by thapsigargin (2.5 µM) on histamine-induced current inhibition. Drugs were bath applied to the cell as indicated by the bars. Insets denote the corresponding current traces recorded. E: summary of KCNQ2/Q3 current inhibitions under the conditions described above. Three, four, and three separate experiments were done to get the statistic data illustrated.

 
We proceeded to test whether the histamine-evoked [Ca2+]i signal was involved in KCNQ2/Q3 modulation. To address this issue, we perform two types of experiments to study the extent of KCNQ2/Q3 current inhibition when such [Ca2+]i rises are suppressed. First, we used different internal solutions containing either 0.1 mM BAPTA (low BAPTA) or 20 mM BAPTA plus 10 mM CaCl2 (high BAPTA) to dialyze cells by whole cell patch recording. The dialysis with low BAPTA internal solution did not disturb [Ca2+]i rises (Fig. 6B, bottom), whereas the dialysis with high BAPTA solution was capable of eliminating [Ca2+]i signals evoked by agonist stimulation (Fig. 6C, bottom) and clamping [Ca2+]i at a physiological level (~170 nM) (1, 7, 33). With a pipette containing low BAPTA solution, the KCNQ2/Q3 currents inhibition induced by 10 µM histamine is 89.1 ± 5.8% (n = 6) after 12 min dialysis (Fig. 6, B and E). For cells dialyzed with high BAPTA solution for the same period, the KCNQ2/Q3 currents were inhibited with a slower time course than that seen in low BAPTA-treated cells. Nevertheless, the current inhibition was 81.3 ± 4.0% (Fig. 6, C and E; n = 11), which was only slightly but not significantly reduced (P > 0.01).

We then tried another approach to prevent the release of Ca2+ from internal Ca2+ stores. We used thapsigargin, a sarcoplasmic-endoplasmic reticulum Ca2+ pump inhibitor, to empty the Ca2+ stores, thus suppressing the [Ca2+]i signals (33). Figure 6D shows such a typical experiment on a HEK293 cell cotransfected with KCNQ2/Q3 channels and H1 receptor. As before, application of 10 µM histamine inhibited KCNQ2/Q3 currents by 90.0 ± 1.6% (Fig. 6, D and E; n = 6). Then the same cell was bath perfused with thapsigargin (2.5 µM) for 5 min to deplete the internal Ca2+ stores. Thapsigargin on its own had little effect on the basal KCNQ2/Q3 currents amplitude during application. A subsequent application of histamine produced a slower but remarkable inhibition of KCNQ2/Q3 currents (Fig. 6, D and E, 88.6 ± 3.9%, n = 6, P > 0.05 vs. control, paired t-test). Thus, although a fast onset of histamine action requires the presence of [Ca2+]i signals, which presumably can promote the PLC activity (23), it is clear that calcium changes are not required for the block of KCNQ2/Q3 currents by histamine.

H1 receptor stimulation does not evoke [Ca2+]i signal in SCG neurons. In rat SCG neurons, PLC-mediated Ca2+ signals diverge among Gq/11-coupled receptors such that activation of bradykinin B2 and purinergic P2Y receptors can induce [Ca2+]i rises from IP3-gated internal Ca2+ stores, whereas muscarinic M1 and angiotensin AT1 receptors cannot. This may be explained by the hypothesis that B2, but not M1, receptor colocalizes with endoplasmic reticulum membrane IP3 receptor to form the "signaling microdomains" that provide easier accesses for released IP3 to bind with IP3 receptor and evoke [Ca2+]i signals (11). Recently, it has been postulated that the mechanisms involved in M current modulation by Gq/11-coupled receptors in SCG neurons may be different based on the ability of receptors to evoke [Ca2+]i signals (44). Thus we began our study by examining whether histamine could evoke [Ca2+]i signals in rat SCG neurons. SCG neurons were bath loaded with fura-2 AM for calcium imaging. We tested histamine and compared it with oxo-M and bradykinin, of which their effects on [Ca2+]i have been well characterized (10). As shown in Fig. 7, A and B, bath application of oxo-M (10 µM) and histamine (10 µM) did not result in a measurable [Ca2+]i signal. However, a subsequent application of high K+ (containing 50 mM K+) solution caused a significant rise in [Ca2+]i. Application of bradykinin (100 nM) evoked an obvious and reversible [Ca2+]i signal (Fig. 7C), which is consistent with the previous report (7). The rises in the F340/380 ratio produced by histamine, oxo-M, and bradykinin were 0.04 ± 0.008 (n = 13), 0.03 ± 0.004 (n = 12), and 0.32 ± 0.05 (n = 7, P < 0.01 vs. oxo-M and histamine, one-way ANOVA), respectively (Fig. 7D). Thus these results suggest that like oxo-M, but unlike bradykinin, histamine does not induce [Ca2+]i rises in rat SCG neurons.


Figure 7
View larger version (14K):
[in this window]
[in a new window]

  		Fig. 7. Histamine does not induce [Ca2+]i signal in SCG neurons. A–C: time courses for changes in F340/F380 ratio of SCG neurons upon application of histamine (10 µM), oxo-M (10 µM), and bradykinin (BK, 100 nM). Extracellular solution containing 50 mM K+ was applied at the end of oxo-M and histamine application to be a positive control. D: summary of the changes in F340/F380 ratio of these studies. Error bars indicate SE. **P < 0.01.

 
Histamine does not require [Ca2+]i signal for M current inhibition in SCG neurons. The inability of histamine to provoke [Ca2+]i signals in SCG neurons lets us hypothesize that histamine and muscarinic modulations of M currents are mediated by a congruent signaling mechanism that does not require a [Ca2+]i signal. Previous work on the actions of [Ca2+]i on M current modulation by GPCR has revealed that Ca2+ is not the messenger for the muscarinic M1 receptor-induced inhibition in rat SCG neurons. On the contrary, Ca2+ is indispensable for bradykinin to achieve its inhibitory effect on M current via B2 receptor (9). Thus we test our hypothesis by [Ca2+]i clamping study and compare its impact among histamine, oxo-M, and bradykinin-induced M current inhibitions in SCG neurons. We probe the effects of these agonists on M currents using pipettes containing either the low BAPTA or high BAPTA internal solutions described above. After several minutes to allow for dialysis by the pipette, neurons were successively challenged with these agonists as indicated. For neurons dialyzed with the low BAPTA internal solutions (Fig. 8A), application of histamine (10 µM), oxo-M (10 µM), and bradykinin (100 nM) suppressed M currents by 38.3 ± 7.9% (n = 6), 98.8 ± 0.4% (n = 6), and 85.3 ± 4.4% (n = 6), respectively. For neurons dialyzed with high BAPTA internal solutions (Fig. 8B), the suppression of M currents by histamine and oxo-M was 32.1 ± 3.1% (n = 10) and 87.3 ± 7.0% (n = 6), which was not significantly altered. In contrast, the inhibitory effect of bradykinin was significantly reduced to 20.5 ± 2.6% (n = 6) (P < 0.01). The results from the above experiments are summarized in Fig. 8C. Thus we suggest that, like oxo-M, but unlike bradykinin, histamine modulation of M current in rat SCG neurons is not mediated by a [Ca2+]i signal, in accordance with its inability to raise [Ca2+]i.


Figure 8
View larger version (18K):
[in this window]
[in a new window]

  		Fig. 8. Intracellular Ca2+ buffering does not block histamine inhibition of M current in SCG neurons. Whole cell recordings of SCG neurons dialyzed by pipettes containing either the low BAPTA (A) or high BAPTA intracellular solution (B). Histamine (10 µM), oxo-M (10 µM), and BK (100 nM) were bath applied during the periods indicated by the bars. Right panels denote the corresponding current traces recorded. C: summarized data of M current inhibition in SCG neurons treated with these agonists either in the low or high BAPTA intracellular solution. **P < 0.01. Error bars indicate SE.

 

   DISCUSSION
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
GRANTS
 REFERENCES
 
In the present work, we demonstrated that histamine, via stimulation of H1 receptor, inhibits KCNQ2/Q3 and M currents in HEK293 cells and rat SCG neurons. The inhibition involves PLC activation and subsequent hydrolysis of membrane PIP2. Histamine also inhibited KCNQ/M currents when intracellular calcium was clamped or Ca2+ stores were depleted. Activation of H1 receptor inhibits M currents in SCG neurons through a similar mechanism described for activation of M1 receptor.

Several lines of evidence indicate that histamine-induced KCNQ/M current inhibition results from PIP2 hydrolysis: 1) The inhibition was mediated via H1 receptor stimulation. H1 receptor is generally believed to couple with Gq/11 to stimulate PLCβ, which catalyzes the hydrolysis of membrane PIP2 (4). 2) U-73122, a PLC inhibitor, significantly antagonized histamine-induced KCNQ/M current inhibition. 3) Treatment with PI4 kinase inhibitor wortmannin or PAO, which blocks the synthesis of PIP2, makes histamine-induced KCNQ2/Q3 currents inhibition irreversible. 4) The reversible translocation of PIP2 fluorescence reporter PLC{delta}1-PH-GFP induced by histamine indicates the hydrolysis of membrane PIP2 in the presence of histamine and its resynthesis upon washout. The time course is also consistent with that of the current inhibition.

Recently, it is proposed that Gq/11 protein-coupled receptors in rat SCG neurons can be divided into two fundamental modes based on their capabilities of depleting membrane PIP2 and evoking [Ca2+]i signals (22, 44). For receptors such as M1, and probably AT1 receptors as well, stimulation of these receptors inhibits M currents via membrane PIP2 depletion (39), but this process is not accompanied with an obvious [Ca2+]i signal. The second mode is well characterized with bradykinin B2 and purinergic P2Y receptors. The stimulation of these receptors will commonly evoke [Ca2+]i signals mediated by IP3. The evoked [Ca2+]i can act as a feedback signal to stimulate the synthesis of PIP2 by PI4 kinase through neuronal calcium sensor-1, concurrently with the activation of PLC (15, 42). Hence, in all, membrane PIP2 level will not fall considerably upon stimulation of these receptors. In this case, M current is inhibited by an alternative pathway that involves Ca2+-mediated CaM modulation of channel (3, 14, 16). In the present study, our results indicate that activation of H1 receptor inhibits M currents in rat SCG neurons through a similar mechanism with that of M1 receptor, since both receptors failed to evoke [Ca2+]i signals.

We noticed that the KCNQ2/Q3 currents were inhibited to a less degree and more slowly in cells either dialyzed with high BAPTA solutions or treated with thapsigargin (Fig. 6, C and D). This is likely due to a reduced rate of PLC activation under the condition of intracellular Ca2+ clamping or reduction. Indeed, it was reported that M1 receptor-induced PIP2 hydrolysis, which was monitored by the translocation of PLC{delta}1-PH-GFP, was slowed and reduced when [Ca2+]i was clamped at resting levels with BAPTA or stores were depleted with thapsigargin (23). Thus, although clamping [Ca2+]i or depletion of Ca2+ stores with the two maneuvers in the present study did not eliminate the large action of histamine, calcium did play a role in promoting a fast onset of histamine action.

The inhibitory effect of histamine on M currents in SCG neurons is slower compared with the fast response in HEK293 cells (Fig. 1, A and D) and to the fast response of M1 receptor agonist Oxo-M in SCC neurons (Fig. 3C). These differences may reflect a lower expression level of histamine H1 receptor and/or lower coupling efficiency between H1 receptors and downstream signaling pathway in native neurons.

In our Ca2+ imaging studies on HEK293 cells and SCG neurons, we saw a marked difference in histamine-evoked [Ca2+]i signals. Histamine induces robust Ca2+ rising in HEK293 cells but failed to provoke [Ca2+]i rising in SCG neurons. Such difference could arise from the existence of a signaling microdomain, formed by specific Gq/11-coupled receptors (e.g., B2 and probably P2Y receptor) with IP3 receptors in native neurons (10) but not in HEK293 cells. In HEK293 cells, such delicate signaling specificity may be greatly disturbed with overexpression of receptors. For this reason, while only activation of B2 and P2Y evokes rising of [Ca2+]i signals in SCG neurons, activation of H1, P2Y, M1, and B2 receptors all induces robust [Ca2+]i rising in HEK293 cells (unpublished data). Thus signaling microdomains such as local PIP2 sequestration by lipid raft (18) or spatial clustering of GPCR and IP3 receptors (11) may confer specificity to receptor-mediated M current modulation in native neurons.

It is worthwhile putting a note on the effects of two different PI4 kinase inhibitors, wortmannin and PAO. Both drugs have been used to block the synthesis of PIP2 by inhibiting PI4 kinase activity (38). In the present study, the KCNQ2/Q3 currents gradually decline upon application of 30 µM wortmannin (Fig. 5A). This likely reflects ongoing endogenous hydrolysis of PIP2 under inhibition of PI4-kinase by wortmannin. On the other hand, PAO transiently but remarkably increases basal KCNQ2/Q3 currents (Fig. 5B). PAO is an arsenic-based compound that affects a variety of cell functions. In addition to its PI4 kinase blocking activity, it is also a potent sulfhydryl oxidant that is capable of altering ion channel functions (35). It is recently reported that oxidative modification can enhance KCNQ/M current by modifying the cysteines in sulfhydryl groups located in channel proteins (19). Therefore, we hypothesize that the transient augmentation of KCNQ2/Q3 currents upon PAO application may be the combined results of oxidative modification of channels and PI4 kinase inhibition.

It is established that functional histamine receptors (H1–H3) are expressed in SCG neurons of many animals, based on electrophysiology studies (5, 6, 28, 31, 36). In our current study, histamine inhibits M current at a concentration of 1 µM and the EC50 is 3.3 µM, which falls in the proposed physiological concentration range (4). There is growing evidence showing that histamine can affect neuronal excitabilities (30, 41, 46). Furthermore, exogenous applied (10 µM) or endogenous histamine released by immunological responses both induced a remarkable membrane depolarization in SCG neurons (5). Since M channels open at resting membrane potential and is considered to be the major contributor to resting membrane potential in SCG neurons (9), thus M current inhibition by physiological concentration of histamine will generally induce membrane depolarization and increase excitability. The inhibitory effect on M current mediated by histamine may provide new insights into the understanding of the excitatory effects of histamine on neurons.


   GRANTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
REFERENCES
 
This work was supported by a NSFC Grant 30730031, National Basic Research Program of China Grant 2007CB512100, and a National 863 Project Grant 2006AA02Z183. H. Zhang is a beneficiary of the National Science Fund for Distinguished Young Scholars of China (No. 30325038).


   ACKNOWLEDGMENTS
 
We thank Zhanfeng Jia, Qingzhong Jia, Zhiying Zhao, and Fan Zhang for technical support.


   FOOTNOTES
 

Address for reprint requests and other correspondence: H. Zhang, Dept. of Pharmacology, Hebei Medical Univ., 361 East Zhongshan Road, Shijiazhuang, Hebei Province, 050017, China (e-mail: zhanghl{at}hebmu.edu.cn)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


   REFERENCES
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
1. Beech DJ, Bernheim L, Mathie A, Hille B. Intracellular Ca2+ buffers disrupt muscarinic suppression of Ca2+ current and M current in rat sympathetic neurons. Proc Natl Acad Sci USA 88: 652–656, 1991.[Abstract/Free Full Text]

2. Brown BS, Yu SP. Modulation and genetic identification of the M channel. Prog Biophys Mol Biol 73: 135–166, 2000.[CrossRef][Web of Science][Medline]

3. Brown DA, Hughes SA, Marsh SJ, Tinker A. Regulation of M (Kv7.2/73) channels in neurons by PIP2 and products of PIP2 hydrolysis: significance for receptor-mediated inhibition. J Physiol 582: 917–925, 2007.[Abstract/Free Full Text]

4. Brown RE, Stevens DR, Haas HL. The physiology of brain histamine. Prog Neurobiol 63: 637–672, 2001.[CrossRef][Web of Science][Medline]

5. Christian EP, Undem BJ, Weinreich D. Endogenous histamine excites neurones in the guinea-pig superior cervical ganglion in vitro. J Physiol 409: 297–312, 1989.[Abstract/Free Full Text]

6. Christian EP, Weinreich D. Presynaptic histamine H1 and H3 receptors modulate sympathetic ganglionic synaptic transmission in the guinea-pig. J Physiol 457: 407–430, 1992.[Abstract/Free Full Text]

7. Cruzblanca H, Koh DS, Hille B. Bradykinin inhibits M current via phospholipase C and Ca2+ release from IP3-sensitive Ca2+ stores in rat sympathetic neurons. Proc Natl Acad Sci USA 95: 7151–7156, 1998.[Abstract/Free Full Text]

8. Dalby-Brown W, Hansen HH, Korsgaard MP, Mirza N, Olesen SP. K(v)7 channels: function, pharmacology and channel modulators. Curr Top Med Chem 6: 999–1023, 2006.[CrossRef][Web of Science][Medline]

9. Delmas P, Brown DA. Pathways modulating neural KCNQ/M (Kv7) potassium channels. Nat Rev Neurosci 6: 850–862, 2005.[CrossRef][Web of Science][Medline]

10. Delmas P, Crest M, Brown DA. Functional organization of PLC signaling microdomains in neurons. Trends Neurosci 27: 41–47, 2004.[CrossRef][Web of Science][Medline]

11. Delmas P, Wanaverbecq N, Abogadie FC, Mistry M, Brown DA. Signaling microdomains define the specificity of receptor-mediated InsP3 pathways in neurons. Neuron 34: 209–220, 2002.[CrossRef][Web of Science][Medline]

12. Filippov AK, Simon J, Barnard EA, Brown DA. Coupling of the nucleotide P2Y4 receptor to neuronal ion channels. Br J Pharmacol 138: 400–406, 2003.[CrossRef][Web of Science][Medline]

13. Ford CP, Stemkowski PL, Smith PA. Possible role of phosphatidylinositol 4, 5 bisphosphate in luteinizing hormone releasing hormone-mediated M-current inhibition in bullfrog sympathetic neurons. Eur J Neurosci 20: 2990–2998, 2004.[CrossRef][Web of Science][Medline]

14. Gamper N, Li Y, Shapiro MS. Structural requirements for differential sensitivity of KCNQ K+ channels to modulation by Ca2+/calmodulin. Mol Biol Cell 16: 3538–3551, 2005.[Abstract/Free Full Text]

15. Gamper N, Reznikov V, Yamada Y, Yang J, Shapiro MS. Phosphatidylinositol 4,5-bisphosphate signals underlie receptor-specific Gq/11-mediated modulation of N-type Ca2+ channels. J Neurosci 24: 10980–10992, 2004.[Abstract/Free Full Text]

16. Gamper N, Shapiro MS. Calmodulin mediates Ca2+-dependent modulation of M-type K+ channels. J Gen Physiol 122: 17–31, 2003.[Abstract/Free Full Text]

17. Gamper N, Shapiro MS. Regulation of ion transport proteins by membrane phosphoinositides. Nat Rev Neurosci 8: 921–934, 2007.[Web of Science][Medline]

18. Gamper N, Shapiro MS. Target-specific PIP2 signaling: how might it work? J Physiol 582: 967–975, 2007.[Abstract/Free Full Text]

19. Gamper N, Zaika O, Li Y, Martin P, Hernandez CC, Perez MR, Wang AY, Jaffe DB, Shapiro MS. Oxidative modification of M-type K+ channels as a mechanism of cytoprotective neuronal silencing. EMBO J 25: 4996–5004, 2006.[CrossRef][Web of Science][Medline]

20. Guo J, Schofield GG. Activation of a PTX-insensitive G protein is involved in histamine-induced recombinant M-channel modulation. J Physiol 545: 767–781, 2002.[Abstract/Free Full Text]

21. Guo J, Schofield GG. Histamine inhibits KCNQ2/KCNQ3 channel current via recombinant histamine H1 receptors. Neurosci Lett 328: 285–288, 2002.[CrossRef][Web of Science][Medline]

22. Hernandez CC, Zaika O, Tolstykh GP, Shapiro MS. Regulation of neural KCNQ channels: signalling pathways, structural motifs and functional implications. J Physiol 586: 1811–1821, 2008.[Abstract/Free Full Text]

23. Horowitz LF, Hirdes W, Suh BC, Hilgemann DW, Mackie K, Hille B. Phospholipase C in living cells: activation, inhibition, Ca2+ requirement, and regulation of M current. J Gen Physiol 126: 243–262, 2005.[Abstract/Free Full Text]

24. Hoshi N, Zhang JS, Omaki M, Takeuchi T, Yokoyama S, Wanaverbecq N, Langeberg LK, Yoneda Y, Scott JD, Brown DA, Higashida H. AKAP150 signaling complex promotes suppression of the M-current by muscarinic agonists. Nat Neurosci 6: 564–571, 2003.[CrossRef][Web of Science][Medline]

25. Jia Q, Jia Z, Zhao Z, Liu B, Liang H, Zhang H. Activation of epidermal growth factor receptor inhibits KCNQ2/3 current through two distinct pathways: membrane PtdIns(4,5)P2 hydrolysis and channel phosphorylation. J Neurosci 27: 2503–2512, 2007.[Abstract/Free Full Text]

26. Jones S, Brown DA, Milligan G, Willer E, Buckley NJ, Caulfield MP. Bradykinin excites rat sympathetic neurons by inhibition of M current through a mechanism involving B2 receptors and G alpha q/11. Neuron 14: 399–405, 1995.[CrossRef][Web of Science][Medline]

27. Li Z, Hatton GI. Histamine-induced prolonged depolarization in rat supraoptic neurons: G-protein-mediated, Ca2+-independent suppression of K+ leakage conductance. Neuroscience 70: 145–158, 1996.[CrossRef][Web of Science][Medline]

28. Lindl T. Effects of histamine agonists and antagonists (H1 and H2) on ganglionic transmission and on accumulation of cyclic nucleotides (cAMP and cGMP) in rat superior cervical ganglion in vitro. Neuropharmacology 22: 203–211, 1983.[CrossRef][Web of Science][Medline]

29. Liu B, Zhang X, Wang C, Zhang G, Zhang H. Antihistamine mepyramine directly inhibits KCNQ/M channel and depolarizes rat superior cervical ganglion neurons. Neuropharmacology 54: 629–639, 2008.[CrossRef][Web of Science][Medline]

30. Ma C, Greenquist KW, Lamotte RH. Inflammatory mediators enhance the excitability of chronically compressed dorsal root ganglion neurons. J Neurophysiol 95: 2098–2107, 2006.[Abstract/Free Full Text]

31. Machova J, Kristofova A. The actions of histamine in cat and rabbit superior cervical ganglia. Agents Actions 23: 260–262, 1988.[CrossRef][Web of Science][Medline]

32. Selyanko AA, Brown DA. Regulation of M-type potassium channels in mammalian sympathetic neurons: action of intracellular calcium on single channel currents. Neuropharmacology 35: 933–947, 1996.[CrossRef][Web of Science][Medline]

33. Shapiro MS, Roche JP, Kaftan EJ, Cruzblanca H, Mackie K, Hille B. Reconstitution of muscarinic modulation of the KCNQ2/KCNQ3 K+ channels that underlie the neuronal M current. J Neurosci 20: 1710–1721, 2000.[Abstract/Free Full Text]

34. Shapiro MS, Wollmuth LP, Hille B. Angiotensin II inhibits calcium and M current channels in rat sympathetic neurons via G proteins. Neuron 12: 1319–1329, 1994.[CrossRef][Web of Science][Medline]

35. Sims C, Harvey RD. Redox modulation of basal and beta-adrenergically stimulated cardiac L-type Ca2+ channel activity by phenylarsine oxide. Br J Pharmacol 142: 797–807, 2004.[CrossRef][Web of Science][Medline]

36. Snow RW, Weinreich D. Presynaptic and postsynaptic effects of histamine and histamine agonists in the superior cervical ganglion of the rat. Neuropharmacology 26: 743–752, 1987.[CrossRef][Web of Science][Medline]

37. Stauffer TP, Ahn S, Meyer T. Receptor-induced transient reduction in plasma membrane PtdIns(4,5)P2 concentration monitored in living cells. Curr Biol 8: 343–346, 1998.[CrossRef][Web of Science][Medline]

38. Suh BC, Hille B. Recovery from muscarinic modulation of M current channels requires phosphatidylinositol 4, 5-bisphosphate synthesis. Neuron 35: 507–520, 2002.[CrossRef][Web of Science][Medline]

39. Suh BC, Hille B. Regulation of ion channels by phosphatidylinositol 4, 5-bisphosphate. Curr Opin Neurobiol 15: 370–378, 2005.[CrossRef][Web of Science][Medline]

40. Wallace DJ, Chen C, Marley PD. Histamine promotes excitability in bovine adrenal chromaffin cells by inhibiting an M-current. J Physiol 540: 921–939, 2002.[Abstract/Free Full Text]

41. Whyment AD, Blanks AM, Lee K, Renaud LP, Spanswick D. Histamine excites neonatal rat sympathetic preganglionic neurons in vitro via activation of H1 receptors. J Neurophysiol 95: 2492–2500, 2006.[Abstract/Free Full Text]

42. Xu C, Watras J, Loew LM. Kinetic analysis of receptor-activated phosphoinositide turnover. J Cell Biol 161: 779–791, 2003.[Abstract/Free Full Text]

43. Zaika O, Lara LS, Gamper N, Hilgemann DW, Jaffe DB, Shapiro MS. Angiotensin II regulates neuronal excitability via phosphatidylinositol 4, 5-bisphosphate-dependent modulation of Kv7 (M-type) K+ channels. J Physiol 575: 49–67, 2006.[Abstract/Free Full Text]

44. Zaika O, Tolstykh GP, Jaffe DB, Shapiro MS. Inositol triphosphate-mediated Ca2+ signals direct purinergic P2Y receptor regulation of neuronal ion channels. J Neurosci 27: 8914–8926, 2007.[Abstract/Free Full Text]

45. Zhang H, Craciun LC, Mirshahi T, Rohacs T, Lopes CM, Jin T, Logothetis DE. PIP2 activates KCNQ channels, and its hydrolysis underlies receptor-mediated inhibition of M currents. Neuron 37: 963–975, 2003.[CrossRef][Web of Science][Medline]

46. Zhou J, Lee AW, Devidze N, Zhang Q, Kow LM, Pfaff DW. Histamine-induced excitatory responses in mouse ventromedial hypothalamic neurons: ionic mechanisms and estrogenic regulation. J Neurophysiol 98: 3143–3152, 2007.[Abstract/Free Full Text]





This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/1/C81    most recent
00028.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, B.
Right arrow Articles by Zhang, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, B.
Right arrow Articles by Zhang, H.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.